Interested in more information about KERENDIA, or want to receive samples? Request the appropriate assistance by completing the form below. A representative from the Bayer team will be in touch shortly.
By submitting the above, I agree to receive information on programs, services, news, and products from Bayer Pharmaceuticals.
Please read our Privacy Statement for more information.
The ADA now recommends KERENDIA in their2022 Standards of Medical Care in Diabetes1
In adult patients with CKD associated with T2D
With KERENDIA,a different pathwayleads to differentpossibilities2,3
KERENDIA offers a different path forward
© 2022 Bayer. All rights reserved. BAYER, the Bayer Cross,
and KERENDIA are registered trademarks of Bayer.
All other trademarks are the property of their respective owners.
Last updated 09/22
You are encouraged to report side effects or quality complaints of products to
the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
Contact us for medical information or questions.